Cumbay MG[au] - Search Results

Year	Number of Results
1998	1
2000	2
2001	3
2002	1
2004	1
2005	1
2021	0

1

Novel regulatory properties of human type 9 adenylate cyclase.

Cumbay MG, Watts VJ. Cumbay MG, et al. J Pharmacol Exp Ther. 2004 Jul;310(1):108-15. doi: 10.1124/jpet.104.065748. Epub 2004 Mar 2. J Pharmacol Exp Ther. 2004. PMID: 14996950

2

Effect of ring fluorination on the pharmacology of hallucinogenic tryptamines.

Blair JB, Kurrasch-Orbaugh D, Marona-Lewicka D, Cumbay MG, Watts VJ, Barker EL, Nichols DE. Blair JB, et al. Among authors: cumbay mg. J Med Chem. 2000 Nov 30;43(24):4701-10. doi: 10.1021/jm000339w. J Med Chem. 2000. PMID: 11101361

3

Re-evaluation of lisuride pharmacology: 5-hydroxytryptamine1A receptor-mediated behavioral effects overlap its other properties in rats.

Marona-Lewicka D, Kurrasch-Orbaugh DM, Selken JR, Cumbay MG, Lisnicchia JG, Nichols DE. Marona-Lewicka D, et al. Among authors: cumbay mg. Psychopharmacology (Berl). 2002 Oct;164(1):93-107. doi: 10.1007/s00213-002-1141-z. Epub 2002 Jul 19. Psychopharmacology (Berl). 2002. PMID: 12373423

4

Heterologous sensitization of recombinant adenylate cyclases by activation of D(2) dopamine receptors.

Cumbay MG, Watts VJ. Cumbay MG, et al. J Pharmacol Exp Ther. 2001 Jun;297(3):1201-9. J Pharmacol Exp Ther. 2001. PMID: 11356947

5

Selective activation of Galphao by D2L dopamine receptors in NS20Y neuroblastoma cells.

Watts VJ, Wiens BL, Cumbay MG, Vu MN, Neve RL, Neve KA. Watts VJ, et al. Among authors: cumbay mg. J Neurosci. 1998 Nov 1;18(21):8692-9. doi: 10.1523/JNEUROSCI.18-21-08692.1998. J Neurosci. 1998. PMID: 9786976 Free PMC article.

6

Galphaq potentiation of adenylate cyclase type 9 activity through a Ca2+/calmodulin-dependent pathway.

Cumbay MG, Watts VJ. Cumbay MG, et al. Biochem Pharmacol. 2005 Apr 15;69(8):1247-56. doi: 10.1016/j.bcp.2005.02.001. Biochem Pharmacol. 2005. PMID: 15794946

7

Adrenergic agonists induce heterologous sensitization of adenylate cyclase in NS20Y-D(2L) cells.

Johnston CA, Cumbay MG, Vortherms TA, Watts VJ. Johnston CA, et al. Among authors: cumbay mg. FEBS Lett. 2001 May 25;497(2-3):85-9. doi: 10.1016/s0014-5793(01)02442-5. FEBS Lett. 2001. PMID: 11377418 Free article.

8

Viral-mediated gene delivery of constitutively activated G alpha s alters vasoreactivity.

Schutzer WE, Watts VJ, Chapman J, Cumbay MG, Neve KA, Neve RL, Mader SL. Schutzer WE, et al. Among authors: cumbay mg. Clin Exp Pharmacol Physiol. 2000 Jan-Feb;27(1-2):9-13. doi: 10.1046/j.1440-1681.2000.03210.x. Clin Exp Pharmacol Physiol. 2000. PMID: 10696522

9

Modeling and mutational analysis of a putative sodium-binding pocket on the dopamine D2 receptor.

Neve KA, Cumbay MG, Thompson KR, Yang R, Buck DC, Watts VJ, DuRand CJ, Teeter MM. Neve KA, et al. Among authors: cumbay mg. Mol Pharmacol. 2001 Aug;60(2):373-81. doi: 10.1124/mol.60.2.373. Mol Pharmacol. 2001. PMID: 11455025

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results